Shanghai Pharmaceutical And Japan Suzuken Establish Joint Venture
This article was originally published in PharmAsia News
Executive Summary
Shanghai Pharmaceutical Co. and Suzuken, Japan's second largest pharmaceutical wholesaler, have officially launched their 50-50 venture. According to Shanghai Pharmaceutical, the new Shanghai-Suzuken company aims to become the first brand name in China to provide pharmaceutical distribution services. In the first year, sales revenue and net profits are estimated to increase by 20 and 30 percent respectively compared to its previous entity. This venture's rate of return tops the local pharmaceutical business equity transfer and Shanghai Pharmaceutical is confident that the collaboration will maximize its short- to long-term interests. Suzuken will introduce its established Japanese products, sales support system, management consulting system and other value-added services to enhance the new firm's competitiveness. (Click here for more - Chinese Language)